Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis

Triple-negative breast cancer (TNBC) tumors do not express estrogen, progesterone or HER2/neu-receptors. There are no specific treatment guidelines for TNBC patients, however, it has been postulated that their phenotypic and molecular similarity to BRCA1-associated cancers would confer sensitivity t...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, MIAO, MO, QIN-GUO, WEI, CHANG-YUAN, QIN, QING-HONG, HUANG, ZHEN, HE, JIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576281/
https://www.ncbi.nlm.nih.gov/pubmed/23426861
http://dx.doi.org/10.3892/ol.2012.1093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576281/
https://www.ncbi.nlm.nih.gov/pubmed/23426861
http://dx.doi.org/10.3892/ol.2012.1093

Ejemplares similares